This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Erdem I. Cantekin, PhD
University of Pittsburgh (Pa)

JAMA. 1993;270(4):449.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—The article by Mandel et al¹ is troubling because it contains the same serious scientific lapses and factual errors that were in an earlier full-length manuscript that I reviewed for JAMA. The accusations of Mandel et al that I have manipulated data, misanalyzed data, engaged in a post hoc alteration of outcome determinations, and engaged in fallacious reasoning are impossible to dispatch in this short space. Last year I provided JAMA with a detailed analysis and refutation of each (written communication, review of manuscript CO2056, May 1992).

The National Institutes of Health, based on its Office of Scientific Integrity (OSI) report, placed Charles D. Bluestone, MD, the principal investigator of the Otitis Media Research Center, on a 5-year special oversight to ensure against real or apparent conflicts of interest because of his undisclosed substantial financial ties to drug companies and his bias in reporting antibiotic efficacy . . . [Full Text PDF of this Article]

Footnotes
Edited by Drummond Rennie, MD, Deputy Editor (West), and Margaret A. Winker, MD, Senior Editor.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?